Features

Ramping up the battle against cardiovascular disease in women represents a golden opportunity to move the needle on mortality.

The moniker is in flux, but patients, clinicians and organizations are embracing the connectedness of virtual hospitals.

For-profit and not-for-profit healthcare facilities may value the health of their cath lab employees differently. Without a clear indication of the bottom-line impact, some hospitals may be forgoing protective equipment and sacrificing the long-term health of their workers. Should the C-suite prioritize worker health when allocating investment dollars? 

Will operators be able to replicate COAPT’s restraint and its outcomes?

With use of cardiac implantable electronic devices on the rise, experts stress device selection, prophylactic antibiotics, pre-procedural protocols and post-implementation vigilance.

Is Interactive Virtual Reality Poised to Deliver a ‘Eureka Moment’ for Cardiology?

In this magazine’s cover story, we examine the work that still needs to be done to improve women’s heart health. Despite significant progress, too many women aren’t even aware that heart disease is relevant to them, let alone their gender’s leading cause of death.

Machine learning tools will support physicians’ efforts to deliver better patient outcomes at lower costs.

Taking the time to build consensus and approaching the task strategically often makes the difference between success and failure. But strategy’s never a substitute for integrity.

Cardiovascular Business asked healthcare administrators for their favorite book recommendations. Here are a few of their responses.

Do you remember the anticipation around renal denervation? And then the ACC.14 presentation of the SYMPLICITY HTN-3 results, where the excitement about a new way to treat resistant hypertension seemed to crash?

Smart technologies are often touted as the answer to some of cardiology’s greatest challenges. But where does hyperbole end and reality begin?